Stable cerasomes for simultaneous drug delivery and magnetic resonance imaging

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 5103-5116

  Cao, Zhong ^a   Zhu, Wenjian ^a   Wang, Wei ^b   Zhang, Chunyang ^a   Xu, Ming ^b   Liu, Jie ^a   Feng, Shi Ting ^c   Jiang, Qing ^a   Xie, Xiaoyan ^b  

^a Guangzhou Universityg   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

MRI; Paclitaxel; SPIO; Superparamagnetic iron oxide

Indexed keywords

LIPOSOMAL CERASOME; LIPOSOME; PACLITAXEL; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MAGNETITE NANOPARTICLE; SILICON DIOXIDE;

ARTICLE; BIOCOMPATIBILITY; CANCER CELL; CANCER INHIBITION; COLORIMETRY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG STABILITY; DRUG STORAGE; DRUG UPTAKE; ENCAPSULATION; HEMOLYSIS; HUMAN; HUMAN CELL; HYDRATION; INTERNALIZATION; LIGHT SCATTERING; MAGNETIC FIELD; MAGNETOMETRY; NUCLEAR MAGNETIC RESONANCE IMAGING; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; VIBRATING SAMPLE MAGNETOMETRY; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; ERYTHROCYTE; HELA CELL LINE; PROCEDURES;

ANTINEOPLASTIC AGENTS; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; ERYTHROCYTES; HELA CELLS; HEMOLYSIS; HUMANS; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; PACLITAXEL; SILICON DIOXIDE;

EID: 84908498011     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S66919     Document Type: Article

References (24)

1. Akbarzadeh A, Mikaeili H, Zarghami N, Mohammad R, Barkhordari A, Davaran S. Preparation and in vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers. Int J Nanomedicine. 2012;7:511-526.
2. Liu T, Qian Y, Hu X, Ge Z, Liu S. Mixed polymeric micelles as multifunctional scaffold for combined magnetic resonance imaging contrast enhancement and targeted chemotherapeutic drug delivery. J Mater Chem. 2012;22:5020-5030.
3. Ma Y, Liang X, Tong S, Bao G, Ren Q, Dai ZF. Gold nanoshell nanomicelles for potential magnetic resonance imaging, light-triggered drug release, and photothermal therapy. Adv Funct Mater. 2013;23(7): 815-822.
4. Ren T, Liu Q, Lu H, Liu H, Zhang X, Du J. Multifunctional polymer vesicles for ultrasensitive magnetic resonance imaging and drug delivery. J Mater Chem. 2012;22:12329-12338.
5. Cheng D, Hong G, Wang W, et al. Nonclustered magnetite nanoparticle encapsulated biodegradable polymeric micelles with enhanced properties for in vivo tumor imaging. J Mater Chem. 2011;21: 4796-4804.
6. Wahajuddin, Arora S. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomedicine. 2012;7: 3445-3471.
7. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4(2):145-160.
8. Frascione D, Diwoky C, Almer G, et al. Ultrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probes. Int J Nanomedicine. 2012;7:2349-2359.
9. Skouras A, Mourtas S, Markoutsa E, et al. Magnetoliposomes with high USPIO entrapping efficiency, stability and magnetic properties. Nanomedicine. 2011;7(5):572-579.
10. Amstad E, Kohlbrecher J, Müller E, Schweizer T, Textor M, Reimhult E. Triggered release from liposomes through magnetic actuation of iron oxide nanoparticle containing membranes. Nano Lett. 2011;11(4): 1664-1670.
11. Mitchell N, Kalber TL, Cooper MS, et al. Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imaging. Biomaterials. 2013;34(4):1179-1192.
12. Faria MR, Cruz MM, Gonçalves MC, Carvalho A, Feio G, Martins MB. Synthesis and characterization of magnetoliposomes for MRI contrast enhancement. Int J Pharm. 2013;446(1-2):183-190.
13. Mikhaylov G, Mikac U, Magaeva AA, et al. Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment. Nat Nanotechnol. 2011;6(9):594-602.
14. Wang B, Zhang L, Bae SC, Granick S. Nanoparticle-induced surface reconstruction of phospholipid membranes. Proc Natl Acad Sci USA. 2008;105(47):18171-18175.
15. Katagiri K, Hashizume M, Ariga K, Terashima T, Kikuchi J. Preparation and characterization of a novel organic-inorganic nanohybrid “cerasome” formed with a liposomal membrane and silicate surface. Chemistry. 2007;13(18):5272-5281.
16. Cao Z, Ma Y, Yue X, Li S, Dai Z, Kikuchi J. Stabilized liposomal nanohybrid cerasomes for drug delivery applications. Chem Commun (Camb). 2010;46(29):5265-5267.
17. Jin Y, Yue X, Zhang Q, Wu X, Cao Z, Dai Z. Cerasomal doxorubicin with long-term storage stability and controllable sustained release. Acta Biomater. 2012;8(9):3372-3380.
18. Wan J, Cai W, Meng X, Liu E. Monodisperse water-soluble magnetite nanoparticles prepared by polyol process for high-performance magnetic resonance imaging. Chem Comm (Camb). 2007;47:5004-5006.
19. Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7(9): 771-782.
20. Cai L, Wang X, Wang W, et al. Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo. Int J Nanomedicine. 2012;7:4499-4510.
21. Yang T, Cui FD, Choi MK, et al. Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. Int J Pharm. 2007;338(1-2):317-326.
22. Sahoo Y, Goodarzi A, Swihart MT, et al. Aqueous ferrofluid of magnetite nanoparticles: fluorescence labeling and magnetophoretic control. J Phys Chem B. 2005;109(9):3879-3885.
23. Nooter K, Stoter G. Molecular mechanisms of multidrug resistance in cancer chemotherapy. Pathol Res Pract. 1996;192(7):768-780.
24. Kim J, Lee JE, Lee SH, et al. Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery. Adv Mater. 2008; 20(3):478-483.